Preparation and in vitro evaluation of ethylcellulose coated egg albumin microspheres of diltiazem hydrochloride

Journal of Young Pharmacists

Volumn 2, Issue 1, 2010, Pages 27-34

  Shailesh, T P ^a   Vipul, P D ^b   Girishbhai, J K ^b   Manish, C J ^c  

^a Shri Sarvajanik Pharmacy College   (India)

^b U T of Dadra and Nagar ^*  (India)

^c L M COLLEGE OF PHARMACY   (India)

Author keywords

Diltiazem hydrochloride; egg albumin microspheres; ethylcellulose; factorial design

Indexed keywords

DILTIAZEM; ETHYL CELLULOSE; MICROSPHERE;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL REACTION KINETICS; CROSS LINKING; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; MATHEMATICAL ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE; TEMPERATURE;

EID: 77956648968     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.62209     Document Type: Article

References (45)

1. Schwartz A, Grupp G, Millard RW. Calcium channel blocks: Possible mechanism of protective effects on the ischemic myocardium. In: Weiss GB (ed.), New Perspectives on Calcium Antagonists. Bethesda, MD: American Physiological Society; 1981. p. 191-210.
2. Buckley MM, Grant SM, Goa KL, McTavish D, Sorkin EM. Diltiazem\a reappraisal of its pharmacological properties and therapeutic use. Drugs 1990;39:757-806.
3. Echizen H, Eichelbaum M. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem. Clin Pharmacokinet 1986;11:425-9.
4. Boden WE, Vray M, Eschwege E, Lauret D, Scheldewaert R. Heart rate-lowering and regulating effects of once-daily sustained-release diltiazem. Clin Cardiol 2001;24:73-9.
5. Murata K, Yamahara H, Kobayashi M, Noda K, Samejima M. Pharma cokinetics of an oral sustained release diltiazem preparation. J Pharm Sci 1989;78:960-3.
6. nd ed., New York: Marcel Dekker Inc; 1987. p. 4-94.
7. Sood A, Pachagnula R Drug release evaluation of diltiazem CR preparations. Int J Pharm 1998;175:95-107.
8. Deboeck AM, Baudier PR. Extended release form of diltiazem, WO/1993/000093, Pct/Ca1992/000290.
9. Vasilevska K, Djuric Z, Jovanovic M, Simov A. Preparation and dissolution characteristics of controlled release diltiazem pellets. Drug Dev Ind Pharm 1992;18;1649-61.
10. Chowdary KP, Ramesh KV, Studies on Microencapsulation of Diltiazem. Indian J Pharm Sci 1993;55:52-4.
11. Horiuchi Y, Hirayama F, Uekama K. Slow release characteristics of diltiazem from ethylated beta-cyclodextrin complexes. J Pharm Sci 1990;79:128-32.
12. Swarbrick J, Boylan JC. Encyclopedia of Pharm. Technology: Vol. 10, Marcel Dekker, Inc: New York; 1990. p. 55 and 199.
13. nd Edi.
14. Robinson JR, Lee, Marcel Dekker Inc.: New York; 1987. p. 217.
15. Celik M. Compaction of multiparticulate oral dosage forms. In: Ghebre-Sellassie I, editor. Multiparticulate oral drug delivery. New York; Marcel Dekker Inc.: 1994. p. 181-215.
16. Bhalerao SS, Lalla JK, Rane MS. Study of processing infuencing the properties of diltiazem hydrochloride microspheres. J Microencapsul 2001;18:299-307.
17. Kim CK, Kim MJ, Oh KH. Preparation and evaluation of sustained release microspheres of terbutaline sulfate. Int J Pharm 1995;106:213-9.
18. Soppimath KS, Kulkarni AR, Aminabhavi TM. Evaluation of antihypertensive drugs in cellulose-based matrix microspheres: Characterization and release kinetics of microspheres and tableted microspheres. J Microencapsul 2001;18:397-409.
19. Das SK, Das NG. Preparation and in vitro dissolution profle of dual polymer (Edragit® RS 100 and RL100) microparticles of diltiazem hydrochloride. J Microencapsul 1998;15:445-52.
20. Kristmundsdottir T., Ingvarsdottir K. Infuence of emulsifying afents on the properties of cellulose acetate butyrate and ethylcellulose microcapsules. J Microencapsul 1994;11:633-9.
21. Kakish HF, Tashtoush B, Ibrahim HG, Najib NM. A novel approach for the preparation of highly loaded polymeric controlled release dosage forms of diltiazem HCl and diclofenac sodium. Eur J Pharm Biopharm 2002;54:75-81.
22. Bayomi MA, al-Suwayeh SA, el-Helw AM, Mesnad AF. Preparation of casein-chitosan microspheres containing diltiaxem hydrochloride by an aqueous coacervation technique. Pharm Acta Helv 1998;73:187-92.
23. Sveinsson SJ, Kristmundsdottir T, Ingvarsdottir K. The effect of tableting on the release of characteristics of naproxen and ibuprofen microcapsules. Int J Pharm 1993;92:29-34.
24. Tirkkonen S, Paronen P. Release of indomethacin from tabletted ethylcellulose microcapsule. Int J Pharm 1993;92:55-62.
25. Sengel CT, Hasçiçek C, Gönül N. Development and in-vitro evaluation of modifed release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride. J Microencapsul 2006;23:135-52.
26. Dubey RR, Parikh JR, Parikh RR. Effect of heating temperature and time on Pharmaceutical characteristics of albumin Microspheres containing 5-Fluorouracil. AAPS PharmSciTech 2003;4:E4.
27. Gupta PK, Hung CT, Lam FC, Perrier DG. Albumin microspheres, III: Synthesis and characterization of microspheres containing Adriamycin and magnetite. Int J Pharm 1988;43:167-77.
28. Dhavan A, Vyas SP, Jain NK, Varma KC. In vitro evaluation of albumin microspheres containing actinomycin, Drug Dev Ind Pharm 1991;17:2229-37.
29. IIIum L, Davis SS. Polymers in controlled drug delivery systems, IOP publishing Ltd., Bristol, 1987.
30. The United States Pharmacopoeia, XXVI. Rockville, MD: The United States: Pharmacopoeia Convention, Inc; 2000. p. 573-6.
31. Mazzo DJ, Obetz CL, Shusten JP. Analytical profles of drug substances and excipients. Britain, Academic press: New York; 1993;23:59.
32. nd ed. Varghese publishing house: Mumbai; 1991. p. 26-7.
33. Al-Saidan SM, Krishnaiah YS, Patro SS, Satyanaryana V. In-vitro and in-vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. AAPS PharmSciTech 2005;6:E14-21.
34. Krishnaiah YS, Karthikeyan RS, Satyanarayana V. Three-layered guar gum matrix tablet formulations for oral controlled delivery of highly soluble metoproplol tartrate. Int J Pharm 2002;241:353-66.
35. Krishnaiah YS, Karthikeyan RS, Gouri Sankar V, Satyanarayana V. Three-layered guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J Control Release 2002;81:45-56. (Pubitemid 34454848)
36. Korsmeyer R, Gurny R, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35. DOI: 10.1016/0378-5173(83) 90064-9 (Pubitemid 13092121)
37. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-11.
38. th Edition, New Central Book Agency (P) Ltd: Kolkata, India; 85-6.
39. Matthews BR. Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 1999;25:831-56.
40. Pongpaibul Y, Price JC, Whitworth CW. Preparation and evaluation of controlled release indomethacin microspheres. Drug Dev Ind Pharm 1984;410:1597-616.
41. Chemtob C, Assimacopoulos T, Chaumeil JC. Preparation and Characteristics of Gelatin Microspheres Drug Dev Ind Pharm 1988;14:1359-74.
42. Maia JL, Santana MH, Re MI, The effect of some processing conditions on the characteristics of biodegradable microspheres obtained by an emulsion solvent evaporation process. Braz J Chem Eng 2004;21:1-12.
43. Gallo JM, Hung CT, Perrier DG. Analysis of albumin microsphere preparation. Int J Pharm 1984;22:63-74.
44. Gupta PK, Hung CT, Perrier DG, Albumin microspheres, II: Effect of stabilization temperature on the release of adriamycin. Int J Pharm 1986;33:147-53.
45. Bamba M, Puisieux F Release mechanisms in gel forming sustained release preparation. Int J Pharm 1979;2:307-15.